In addition, there are other findings in adenocarcinoma of the lung, such as differential expression of GABPB1 in different molecular subtypes and correlations between GABPB1 expression and activation-related signalling pathways, such as apoptosis, the cell cycle, and epithelial–mesenchymal transition (EMT). This evidence concerns the gene GABPB1 and lung adenocarcinoma.